Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study

OBJECTIVES: Current irritable bowel syndrome (IBS) treatments have limited efficacy and probiotics like Bacillus clausii (B. clausii) were found to be effective in the management of several gastrointestinal disorders. This phase III trial assessed the efficacy and safety of adding B. clausii (four s...

Descripción completa

Detalles Bibliográficos
Autores principales: Vázquez-Frias, Rodrigo, Consuelo-Sánchez, Alejandra, Acosta-Rodríguez-Bueno, Carlos Patricio, Blanco-Montero, Andrés, Robles, Daniel Casas, Cohen, Vanessa, Márquez, Daniel, Perez, Marcos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666949/
https://www.ncbi.nlm.nih.gov/pubmed/36380186
http://dx.doi.org/10.1007/s40272-022-00536-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666949/
https://www.ncbi.nlm.nih.gov/pubmed/36380186
http://dx.doi.org/10.1007/s40272-022-00536-9

Ejemplares similares